Court Intrusion Into Science and Medicine-The Mifepristone Decisions

Daniel G Aaron; Teneille R Brown; Michael S Sinha

doi:10.1001/jama.2023.7790

Court Intrusion Into Science and Medicine-The Mifepristone Decisions

JAMA. 2023 May 23;329(20):1735-1737. doi: 10.1001/jama.2023.7790.

Authors

Daniel G Aaron^{1

2}, Teneille R Brown³, Michael S Sinha⁴

Affiliations

¹ S.J. Quinney College of Law at the University of Utah, Salt Lake City.
² US Court of Appeals for the Sixth Circuit, Louisville, Kentucky.
³ Center for Law and the Biomedical Sciences, S.J. Quinney College of Law at the University of Utah, Salt Lake City.
⁴ Center for Health Law Studies, Saint Louis University School of Law, St Louis, Missouri.

PMID: 37099527
DOI: 10.1001/jama.2023.7790

No abstract available

Plain language summary

This Viewpoint discusses recent US court decisions on the availability of mifepristone, a drug used to terminate pregnancies, and how these conflicting court decisions affect the scientific process and decision-making of the US Food and Drug Administration.

MeSH terms

Abortion, Induced* / legislation & jurisprudence
Female
Humans
Legislation, Medical*
Medicine
Mifepristone* / therapeutic use
Pregnancy
Science* / legislation & jurisprudence
Supreme Court Decisions*
United States

Substances

Mifepristone